Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-5038
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMattli, Renato-
dc.contributor.authorEichler, Klaus-
dc.contributor.authorPletscher, Mark-
dc.contributor.authorWieser, Simon-
dc.date.accessioned2019-03-07T13:54:13Z-
dc.date.available2019-03-07T13:54:13Z-
dc.date.issued2013-
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/15874-
dc.description.abstractFebrile neutropenia (FN) can be a serious complication of chemotherapy (CHT), increasing mortality risk and healthcare costs. Incidence and inpatient hospital costs of FN in Switzerland are currently not reported. The study aimed to: 1. Estimate the number of CHT induced FN-related hospitalizations. 2. Assess inpatient hospital costs per FN event in Switzerland.de_CH
dc.language.isoende_CH
dc.publisherZHAW Zürcher Hochschule für Angewandte Wissenschaftende_CH
dc.rightsLicence according to publishing contractde_CH
dc.subject.ddc362: Gesundheits- und Sozialdienstede_CH
dc.titleInpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and non-Hodgkin lymphoma in Switzerlandde_CH
dc.typeKonferenz: Posterde_CH
dcterms.typeTextde_CH
zhaw.departementSchool of Management and Lawde_CH
dc.identifier.doi10.21256/zhaw-5038-
zhaw.conference.detailsISPOR 16th Annual European Congress, Dublin, Ireland, 2-6 November 2013de_CH
zhaw.funding.euNode_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.publication.reviewPeer review (Abstract)de_CH
Appears in Collections:Publikationen School of Management and Law



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.